JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
399 * ! Tue, 8/11/2015, 2:00 PM - 3:50 PM CC-608
Evaluation of Strategies to Assess Cardiovascular Risk in Patients with Type 2 Diabetes — Invited Papers
ENAR , Health Policy Statistics Section
Organizer(s): Qi Jiang, Amgen
Chair(s): Qi Jiang, Amgen
2:05 PM Assessing CV Risk in T2DM Products: Regulatory Experiences and Examples at CDER/FDA — Janelle K. Charles, FDA
2:25 PM Are There Alternative Strategies to the Current Practice of Large Cardiovascular Outcome Trials for Assessing CV Risk of Products for Type 2 Diabetes? — Christy Chuang-Stein, Pfizer Inc.
2:45 PM Discussant: Estelle Russek-Cohen, FDA
3:05 PM Discussant: Matilde Sanchez-Kam, Arena Pharmaceuticals
3:25 PM Discussant: Frank Rockhold, GSK
3:45 PM Floor Discussion




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home